Johnf Burd News Today

DexCom (NASDAQ:DXCM – Get Rating) and Nuvectra (OTCMKTS:NVTRQ – Get Rating) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, institutional ownership, analyst recommendations, earnings, profitability, valuation and dividends. Analyst Recommendations This is a summary of current ratings and target prices […]

DexCom (NASDAQ:DXCM – Get Rating) and Valeritas (OTCMKTS:VLRXQ – Get Rating) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their risk, dividends, valuation, institutional ownership, profitability, earnings and analyst recommendations. Insider and Institutional Ownership 94.0% of DexCom shares are owned by institutional […]

DexCom (NASDAQ:DXCM – Get Rating) and Axonics (NASDAQ:AXNX – Get Rating) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, valuation, earnings, institutional ownership, analyst recommendations and dividends. Analyst Recommendations This is a breakdown of recent ratings and price targets […]

Axonics (NASDAQ:AXNX – Get Rating) and DexCom (NASDAQ:DXCM – Get Rating) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, risk, profitability, valuation, earnings and dividends. Risk and Volatility Axonics has a beta of 0.39, suggesting that its […]

Axonics (NASDAQ:AXNX – Get Rating) and DexCom (NASDAQ:DXCM – Get Rating) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, institutional ownership and valuation. Analyst Recommendations This is a summary of recent ratings for Axonics and […]